third generation glp 1 Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Glucagon Receptor Agonist) third generation glp 1 Understanding
Description
Some patients still notice a clear onset
This mechanism makes it especially attractive for patients with obesity complicated by metabolic disorders such as type 2 diabetes and metabolic dysfunctionassociated fatty liver disease (MAFLD)
GLP-1 receptor agonist meds help regulate blood glucose by stimulating insulin secretion when blood sugar levels are high and reducing glucagon release to prevent spikes
By amplifying these signals, Wegovy reduces hunger, curbs cravings, and makes it easier for patients to stick to a lower-calorie diet
